share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股sec公告 ·  05/30 11:53
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,350 shares of common stock on 05/30/2024, with an aggregate market value of approximately $1,031,908. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction from the issuer. There have been no other securities sold by Tatsis in the past three months prior to the notice date of the planned sale.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,350 shares of common stock on 05/30/2024, with an aggregate market value of approximately $1,031,908. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction from the issuer. There have been no other securities sold by Tatsis in the past three months prior to the notice date of the planned sale.
Vertex Pharmicals Inc.高管欧拉尼亚·塔西斯定于2024年5月30日出售2350股普通股,总市值约为1,031,908美元。这些股票于2024年2月24日作为限制性股票归属的一部分收购,这是发行人与薪酬相关的交易。在计划出售的通知日期之前的过去三个月中,塔西斯没有出售其他证券。
Vertex Pharmicals Inc.高管欧拉尼亚·塔西斯定于2024年5月30日出售2350股普通股,总市值约为1,031,908美元。这些股票于2024年2月24日作为限制性股票归属的一部分收购,这是发行人与薪酬相关的交易。在计划出售的通知日期之前的过去三个月中,塔西斯没有出售其他证券。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息